More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
CNBC - 2024-04-24T09:00:01.000Z

For the first time, some Medicare beneficiaries will be able to access Novo Nordisk's Wegovy without having to shoulder the total monthly price tag.

In related news

Oxford Study: COVID-19 Vaccines Dramatically Reduce Disease Severity
A groundbreaking study by scientists at the University of Oxford reveals that COVID-19 vaccines, particularly the ChAdOx1 nCoV-19 vaccine, drastically reduce future disease severity.
- Related Articles
- In News
- From Tech Times
- 2024-05-03T15:47:51.000Z
Data breach may have involved millions of patients, Kaiser says. What was leaked?
Kaiser Permanente is notifying 13.4 million patients their data may have been sent to Google, X and other third-party vendors.
- Related Articles
- In News
- From Miami Herald
- 2024-04-29T18:20:00.000Z
1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban
Medicare is prohibited from covering weight loss medications due to the Medicare Modernization Act of 2003.
- Related Articles
- In News
- From WWLP.com
- 2024-04-24T10:02:19.000Z